MariMed Inc. (MRMD)

OTCMKTS · Delayed Price · Currency is USD
0.0750
0.00 (0.00%)
At close: May 22, 2026
Market Cap29.94M -22.1%
Revenue (ttm)161.40M +2.2%
Net Income-12.76M
EPS-0.04
Shares Out399.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume799,265
Average Volume776,498
Open0.0700
Previous Close0.0750
Day's Range0.06915 - 0.0767
52-Week Range0.0641 - 0.2300
Beta1.34
RSI46.02
Earnings DateMay 13, 2026

About MariMed

MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature’s Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty’s Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under ... [Read more]

Sector Healthcare
Founded 2011
Employees 923
Stock Exchange OTCMKTS
Ticker Symbol MRMD
Full Company Profile

Financial Performance

In 2025, MariMed's revenue was $159.83 million, an increase of 1.34% compared to the previous year's $157.71 million. Losses were -$14.48 million, 16.2% more than in 2024.

Financial Statements

News

MariMed Earnings Call Transcript: Q1 2026

Q1 2026 saw 4% revenue growth year-over-year, stable gross margins, and improved profitability, driven by strong wholesale and retail performance in core markets. Expansion is planned in Massachusetts and Ohio, with immediate tax benefits expected from medical cannabis rescheduling.

10 days ago - Transcripts

MariMed Earnings release: Q1 2026

MariMed released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.

10 days ago - Filings

MariMed Slides: Q1 2026

MariMed has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.

10 days ago - Filings

MariMed Quarterly report: Q1 2026

MariMed has published its Q1 2026 quarterly earnings report on May 14, 2026.

10 days ago - Filings

MariMed Reports First Quarter 2026 Earnings

NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, toda...

10 days ago - GlobeNewsWire

MariMed Proxy statement: Proxy filing

MariMed filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.

4 weeks ago - Filings

MariMed Announces First Quarter 2026 Earnings Date

NORWOOD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today...

5 weeks ago - GlobeNewsWire

MariMed Earnings Call Transcript: Q4 2025

Revenue grew 7% to $160M in 2025, with strong wholesale gains and expanded brand reach via licensing. Margin discipline, positive cash flow, and a strengthened balance sheet position the company for further growth, despite ongoing price compression in mature markets.

2 months ago - Transcripts

MariMed Annual report: Q4 2025

MariMed has published its Q4 2025 annual report on March 12, 2026.

2 months ago - Filings

MariMed Earnings release: Q4 2025

MariMed released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.

2 months ago - Filings

MariMed Slides: Q4 2025

MariMed has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.

2 months ago - Filings

MariMed Reports Fourth Quarter and Full Year 2025 Earnings

NORWOOD, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, to...

2 months ago - GlobeNewsWire

MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure

NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today...

2 months ago - GlobeNewsWire

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today ...

3 months ago - GlobeNewsWire

Marimed’s Betty’s Eddies introductions ‘Berry in Love Betty’

Betty’s Eddies is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine’s Day: Berry In Love Betty. Now available at MariMed’s (MRMD) Thrive…

3 months ago - TheFly

Marimed launches hemp-derived THC products under Vibations brand

MariMed (MRMD) announced the launch of a hemp-derived THC version of its Vibations hydrating drink mix brand in Rhode Island. The launch represents an opportunity for the Company to expand…

4 months ago - TheFly

Marimed commends Trump Administration for reclassifying cannabis to Schedule III

MariMed (MRMD) issued the following statement from CEO Jon Levine: “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single…

5 months ago - TheFly

MariMed Statement on Historic Rescheduling of Cannabis

NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the followi...

5 months ago - GlobeNewsWire

Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries

Veteran and customer of Thrive Dispensary in Anna, IL writes song of appreciation for Thrive and to raise visibility for veteran's org FreedomSingsUSA.

5 months ago - GlobeNewsWire

Marimed’s Betty’s Eddies expands lineup of chews for the winter

Betty’s Eddies is expanding its lineup with a new limited-edition batch of cranberry orange chews for the winter: Bundle Up Betty’s. Betty’s Eddies is one of the top-selling and award-winning…

6 months ago - TheFly

MariMed's Betty's Eddies™ Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty's

Bundle Up Betty's Uses Real Cranberry, Orange, and Warming Spices in Each Fruit Chew to Deliver Cozy Winter Wind-Downs Bundle Up Betty's Uses Real Cranberry, Orange, and Warming Spices in Each Fruit C...

6 months ago - GlobeNewsWire

MariMed Earnings Call Transcript: Q3 2025

Q3 saw sequential growth in wholesale and retail revenue, with strong brand performance in core markets and a shift toward wholesale driving margin stability. Expansion into hemp and new licensing deals support long-term growth, while cost discipline improved cash flow and EBITDA.

7 months ago - Transcripts

MariMed Quarterly report: Q3 2025

MariMed has published its Q3 2025 quarterly earnings report on November 6, 2025.

7 months ago - Filings

MariMed Earnings release: Q3 2025

MariMed released its Q3 2025 earnings on November 6, 2025, summarizing the period's financial results.

7 months ago - Filings

MariMed Reports Third Quarter 2025 Earnings

NORWOOD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, tod...

7 months ago - GlobeNewsWire